CECCHINI, DEBORA
 Distribuzione geografica
Continente #
NA - Nord America 448
EU - Europa 442
AS - Asia 178
AF - Africa 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.073
Nazione #
US - Stati Uniti d'America 447
IT - Italia 170
IE - Irlanda 123
SG - Singapore 50
HK - Hong Kong 46
CN - Cina 43
SE - Svezia 32
RO - Romania 28
VN - Vietnam 24
FI - Finlandia 23
RU - Federazione Russa 12
DE - Germania 10
FR - Francia 9
UA - Ucraina 8
BE - Belgio 7
CZ - Repubblica Ceca 6
KR - Corea 6
GB - Regno Unito 5
CI - Costa d'Avorio 4
PL - Polonia 3
UZ - Uzbekistan 3
CH - Svizzera 2
IN - India 2
TR - Turchia 2
AT - Austria 1
CA - Canada 1
EU - Europa 1
GR - Grecia 1
ID - Indonesia 1
IM - Isola di Man 1
JP - Giappone 1
LT - Lituania 1
Totale 1.073
Città #
Dublin 123
Chandler 95
Perugia 88
San Mateo 65
Hong Kong 46
Singapore 45
Boardman 30
Bucharest 28
Dong Ket 24
Altamura 23
Ann Arbor 23
Santa Clara 19
Beijing 16
Helsinki 15
Lawrence 14
Medford 14
Princeton 14
New York 11
Wilmington 11
Assisi 10
Foligno 8
Andover 7
Brussels 7
Redwood City 7
Seoul 6
Dallas 5
Dearborn 5
Falls Church 5
Los Angeles 5
Norwalk 5
Saint Petersburg 5
Abidjan 4
Bastia 4
Brno 4
Munich 4
Ashburn 3
Des Moines 3
Guangzhou 3
Houston 3
San Paolo di Civitate 3
Changsha 2
Jacksonville 2
Macerata 2
Melissa 2
West Jordan 2
Apo 1
Battipaglia 1
Bekasi 1
Bhubaneswar 1
Campobasso 1
Delhi 1
Douglas 1
Frankfurt Am Main 1
Hanover 1
Hefei 1
Izmir 1
Kocaeli 1
L'aquila 1
Ludwigshafen 1
Moscow 1
Nanjing 1
Olomouc 1
Ottawa 1
Paris 1
Redmond 1
San Benedetto Del Tronto 1
Selargius 1
Spello 1
Tashkent 1
Tokyo 1
Vienna 1
Woodbridge 1
Totale 847
Nome #
Bepridil exhibits anti-leukemic activity associated with NOTCH1 pathway inhibition in chronic lymphocytic leukemia 131
Notch1 modulates mesenchymal stem cells mediated regulatory T-cell induction 109
The NOTCH1/CD39 axis: A Treg trip-switch for GvHD 80
Clinical-Grade Expanded Regulatory T Cells Prevent Graft-versus-Host Disease While Allowing a Powerful T Cell Dependent Graft-versus-Leukemia Effect in Murine Models 74
NPM1 AND FLT3-ITD MUTATIONS SINERGISTICALLY INDUCE GATA1 EPIGENETIC SILENCING IN A AML MOUSE MODEL 72
Decreased NOTCH1 Activation Correlates with Response to Ibrutinib in Chronic Lymphocytic Leukemia 71
GATA1 epigenetic deregulation contributes to the development of AML with NPM1 and FLT3-ITD cooperating mutations 69
T regulatory cell separation for clinical application. 67
IN VITRO AND IN VIVO ANTILEUKEMIC ACTIVITY OF BEPRIDIL IN CHRONIC LYMPHOCYTIC LEUKEMIA IS ASSOCIATED WITH INHIBITION OF THE NOTCH1 PATHWAY 59
HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse 57
HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse 56
The human NPM1 mutation A perturbs megakaryopoiesis in a conditional mouse model. 51
Mesenchymal cells recruit and regulate T regulatory cells. 45
BEPRIDIL IS A POTENT NOTCH1 INHIBITOR AND EFFICIENTLY INDUCES APOPTOSIS IN CHRONIC LYMPHOCYTIC LEUKAEMIA (CLL) CELLS in vitro AND in vivo 44
CURCUMIN EXHIBITS IN VITRO AND IN VIVO ANTI-LEUKEMIC ACTIVITY INTERFERING WITH THE NOTCH1 PATHWAY AND INDUCING ENDOPLASMIC RETICULUM STRESS IN CHRONIC LYMPHOCYTIC LEUKEMIA 42
Gefitinib enhances the effects of combined radiotherapy and 5-fluorouracil in a colorectal cancer cell line. 39
A NOVEL MECHANISM FOR NOTCH1 ACTIVATIONIN CHRONIC LYMPHOCYTIC LEUKEMIA CELLS: INVOLVEMENT OF NOTCH1 ENDOSOMAL TRAFFICKING AND ALTERATIONS IN RAB PROTEINS 34
NOTCH-1 ACTIVATION AND SUBCLONAL MUTATION NEGATIVELY IMPACT ON CHRONIC LYMPHOCYTIC LEUKEMIA OUTCOMES 31
Totale 1.131
Categoria #
all - tutte 5.620
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.620


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202047 0 0 0 0 0 5 2 5 3 30 1 1
2020/2021111 4 2 3 3 31 8 6 2 12 5 10 25
2021/2022253 7 54 1 4 9 3 6 36 3 36 49 45
2022/2023325 14 70 1 20 31 25 0 18 125 1 14 6
2023/2024176 7 15 6 16 0 11 53 2 3 11 26 26
2024/2025106 11 36 12 12 24 11 0 0 0 0 0 0
Totale 1.131